Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for Ani Pharmaceuticals (ANIP) over the last 15 years, with Sep 2025 value amounting to $6.5 million.

  • Ani Pharmaceuticals' Other Working Capital Changes rose 415.60% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 50.47%. This contributed to the annual value of -$2.1 million for FY2024, which is 123.62% down from last year.
  • Per Ani Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $6.5 million for Q3 2025, which was up 165.62% from -$9.8 million recorded in Q2 2025.
  • Ani Pharmaceuticals' 5-year Other Working Capital Changes high stood at $8.4 million for Q4 2023, and its period low was -$9.8 million during Q2 2025.
  • Over the past 3 years, Ani Pharmaceuticals' median Other Working Capital Changes value was $64,000 (recorded in 2023), while the average stood at $677,273.
  • Examining YoY changes over the last 5 years, Ani Pharmaceuticals' Other Working Capital Changes showed a top increase of 415.60% in 2025 and a maximum decrease of 2,219.58% in 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at $1.3 million in 2021, then spiked by 163.91% to $3.4 million in 2022, then soared by 145.36% to $8.4 million in 2023, then tumbled by 79.79% to $1.7 million in 2024, then surged by 415.60% to $6.5 million in 2025.
  • Its Other Working Capital Changes was $6.5 million in Q3 2025, compared to -$9.8 million in Q2 2025 and $3.9 million in Q1 2025.